Tiantan bio
Tiantan bio diagnostic supplies and other biological products
Tiantan Bio is a vaccine reagent developer, focusing on the research and production of vaccines, blood preparations, diagnostic supplies and other biological products, mainly to provide users with hepatitis B vaccine, polio vaccine, MMR vaccine, influenza vaccine, chickenpox vaccine and other products, its own Changchun Chijian Biological Products Co.
Heavy bomb in the field of hypoglycemic! Lilly tirzepatide approved for listing
EqualOcean Sector Quarterly Report - Healthcare Sectors
To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.
Apr 07, 2022 01:44 PM
Roche PD-L1 combined with tigit failed in the first-line treatment of stage III non-small cell lung cancer with high expression of PD-L1
Foreign media said Green Valley pharmaceutical Alzheimer's disease new drug phase IX phase I ® The international phase III clinical trial has been stopped
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Technology, Consumer Staples, Real EstateTech for Global, Globalization Footprints of the Established and the New
The new drug registration of step pharmaceutical subsidiary was terminated, and 7.6 million R & D expenses have been invested
Pfizer acquired biohaven for about US $11.6 billion to expand the product pipeline of nervous system diseases
Medtronic's world's first self expanding pulmonary valve was first-class recalled
Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use
R&D of Anti-COVID-19 Drugs is Blooming in China
Anti-epidemic stocks moved higher in early trading of the Hong Kong Stock Exchange today, with Kintor Pharma-B (Chinese: 开拓药业,09939:HK) and Shandong Xinhua Pharmaceutical (Chinese: 新华制药,00719:HK) leading the rally on the back of thriving R&D of anti-coronavirus drugs.
Updated 39 mins ago
The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.
Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus
Five departments including the central bank: encourage financial institutions to incorporate the application of open source technology into their informatization development plans